{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:33:35Z","timestamp":1788212015965,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006389","name":"Universit\u00e9 de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["205321_192350"],"award-info":[{"award-number":["205321_192350"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejpb.2026.114980","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:53:57Z","timestamp":1767891237000},"page":"114980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cationic liposome-mediated intra-articular delivery of lorecivivint for osteoarthritis treatment"],"prefix":"10.1016","volume":"220","author":[{"given":"Paula","family":"Gonzalez-Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7102-1285","authenticated-orcid":false,"given":"Luca","family":"Morici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Simula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajhi","family":"Takwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Benabdellah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"All\u00e9mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3752-2198","authenticated-orcid":false,"given":"Olivier","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejpb.2026.114980_b0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","article-title":"Osteoarthritis: pathology, diagnosis, and treatment options","volume":"104","author":"Abramoff","year":"2020","journal-title":"Med. Clin. N. Am."},{"issue":"12","key":"10.1016\/j.ejpb.2026.114980_b0010","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41584-020-00518-6","article-title":"Emerging pharmaceutical therapies for osteoarthritis","volume":"16","author":"Latourte","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.ejpb.2026.114980_b0015","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","article-title":"Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions","volume":"53","author":"Cho","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.ejpb.2026.114980_b0020","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.drudis.2018.05.023","article-title":"Recent advances in intra-articular drug delivery systems for osteoarthritis therapy","volume":"23","author":"Maudens","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.ejpb.2026.114980_b0025","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/13543784.2020.1842357","article-title":"Lorecivivint, an intra-articular potential disease-modifying osteoarthritis drug","volume":"29","author":"Sabha","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ejpb.2026.114980_b0030","article-title":"Update on clinical trials of intra-articular disease-modifying osteoarthritis drugs inducing cartilage regeneration","author":"Morici","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.114980_b0035","first-page":"7631","article-title":"Cross-talk between TGF-\u03b2\/Smad pathway and Wnt\/\u03b2-catenin pathway in pathological scar formation","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejpb.2026.114980_b0040","doi-asserted-by":"crossref","first-page":"14002","DOI":"10.1038\/boneres.2014.2","article-title":"TGF-\u03b2 signaling and the development of osteoarthritis","volume":"2","author":"Shen","year":"2014","journal-title":"Bone Res."},{"issue":"5","key":"10.1016\/j.ejpb.2026.114980_b0045","first-page":"847","article-title":"A phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients","volume":"43","author":"Yazici","year":"2025","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.ejpb.2026.114980_b0050","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.joca.2019.05.006","article-title":"Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment","volume":"27","author":"Deshmukh","year":"2019","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.joca.2017.08.015","article-title":"A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee","volume":"26","author":"Deshmukh","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejpb.2026.114980_b0060","article-title":"Nanocrystal-chitosan particles for intra-articular delivery of disease-modifying osteoarthritis drugs","author":"Morici","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2026.114980_b0065","article-title":"Nanocrystal-polymer particles: extended delivery carriers for osteoarthritis treatment","volume":"14","author":"Maudens","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2026.114980_b0070","unstructured":"L. Morici, J. Olivier, A. Eric, C. Rodr\u00edguez-Nogales, Recent advances in nanocrystals for arthritis drug delivery. Exp. Opin. Drug Deliv. null-null."},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1208\/s12249-021-02149-w","article-title":"Intra-articular injection of lornoxicam and MicroRNA-140 co-loaded cationic liposomes enhanced the therapeutic treatment of experimental osteoarthritis","volume":"23","author":"He","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.114980_b0080","article-title":"Injectable hydrogel microspheres with self-renewable hydration layers alleviate osteoarthritis","volume":"8(5)","author":"Lei","year":"2022","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.ejpb.2026.114980_b0085","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.chemphyslip.2011.11.007","article-title":"Liposomes as lubricants: beyond drug delivery","volume":"165","author":"Goldberg","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejpb.2026.114980_b0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.wear.2009.12.037","article-title":"Liposomes as potential biolubricant additives for wear reduction in human synovial joints","volume":"268","author":"Verberne","year":"2010","journal-title":"Wear"},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0095","article-title":"Recent advances in clinical translation of intra-articular osteoarthritis drug delivery systems","volume":"4","author":"DeJulius","year":"2021","journal-title":"Adv. Ther. (Weinh.)"},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0100","doi-asserted-by":"crossref","first-page":"25876","DOI":"10.1038\/srep25876","article-title":"Liposome production by microfluidics: potential and limiting factors","volume":"6","author":"Carugo","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejpb.2026.114980_b0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrrheum.2016.210","article-title":"Cartilage-targeting drug delivery: can electrostatic interactions help?","volume":"13","author":"Bajpayee","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"10.1016\/j.ejpb.2026.114980_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11120653","article-title":"The impact of solvent selection: strategies to guide the manufacturing of liposomes using microfluidics","volume":"11","author":"Webb","year":"2019","journal-title":"Pharmaceutics"},{"issue":"14","key":"10.1016\/j.ejpb.2026.114980_b0115","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1021\/acs.langmuir.0c00475","article-title":"Mechanical properties determination of DMPC, DPPC, DSPC, and HSPC solid-ordered bilayers","volume":"36","author":"Drabik","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2026.114980_b0120","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.biomaterials.2013.03.098","article-title":"Origins of extreme boundary lubrication by phosphatidylcholine liposomes","volume":"34","author":"Sorkin","year":"2013","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ejpb.2026.114980_b0125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/la9024712","article-title":"Liposomes act as effective biolubricants for friction reduction in human synovial joints","volume":"26","author":"Sivan","year":"2010","journal-title":"Langmuir"},{"issue":"6","key":"10.1016\/j.ejpb.2026.114980_b0130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.bpj.2023.01.031","article-title":"DOTAP: structure, hydration, and the counterion effect","volume":"122","author":"Mihailescu","year":"2023","journal-title":"Biophys. J."},{"issue":"10, Part A","key":"10.1016\/j.ejpb.2026.114980_b0135","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bbamem.2015.06.020","article-title":"DOTAP\/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes","volume":"1848","author":"Kim","year":"2015","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejpb.2026.114980_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.joca.2020.02.545","article-title":"Protein corona formation on particles in bovine synovial fluid and in a rat knee model of osteoarthritis","volume":"28","author":"Shah","year":"2020","journal-title":"Osteoarthr. Cartil."},{"issue":"10","key":"10.1016\/j.ejpb.2026.114980_b0145","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.joca.2022.07.002","article-title":"Synovial fluid profile dictates nanoparticle uptake into cartilage - implications of the protein corona for novel arthritis treatments","volume":"30","author":"von Mentzer","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejpb.2026.114980_b0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.actbio.2022.08.010","article-title":"Charge-based drug delivery to cartilage: hydrophobic and not electrostatic interactions are the dominant cause of competitive binding of cationic carriers in synovial fluid","volume":"151","author":"Vedadghavami","year":"2022","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28010010","article-title":"Quality by design approach in liposomal formulations: robust product development","volume":"28","author":"Alshaer","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.114980_b0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00003086-198810000-00029","article-title":"Synovial fluid osmolality in osteoarthritis and rheumatoid arthritis","volume":"235","author":"Shanfield","year":"1988","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2026.114980_b0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0749-8063(88)80023-9","article-title":"The changes in human synovial fluid osmolality associated with traumatic or mechanical abnormalities of the knee","volume":"4","author":"Newman","year":"1988","journal-title":"Arthroscopy"},{"issue":"11","key":"10.1016\/j.ejpb.2026.114980_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306722","article-title":"Osmolarity-induced altered intracellular molecular crowding drives osteoarthritis pathology","volume":"11","author":"Govindaraj","year":"2024","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2026.114980_b0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/art.1780140407","article-title":"Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases","volume":"14","author":"Treuhaft","year":"1971","journal-title":"Arthr. Rheumat."},{"key":"10.1016\/j.ejpb.2026.114980_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124843","article-title":"Cartilage-targeted drug nanocarriers for osteoarthritis therapy","volume":"666","author":"Morici","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.114980_b0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2020.01.052","article-title":"The clearance and biodistribution of magnetic composite nanoparticles in healthy and osteoarthritic rat knees","volume":"321","author":"Partain","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0190","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1038\/s41467-023-41946-8","article-title":"Aromatized liposomes for sustained drug delivery","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ejpb.2026.114980_b0195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1557\/s43578-021-00105-9","article-title":"Preparation and in vitro evaluation of PEGylated liposomes as effective nanocarrier for delivery of oxaliplatin","volume":"36","author":"Le","year":"2021","journal-title":"J. Mater. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2026.114980_b0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08982104.2019.1634724","article-title":"Liposome-based codelivery of celecoxib and doxorubicin hydrochloride as a synergistic dual-drug delivery system for enhancing the anticancer effect","volume":"30","author":"Ahmed","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2026.114980_b0205","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.joca.2025.02.171","article-title":"Extended and controlled release liposomal formulated dexamethasone (TLC599) for chronic knee osteoarthritis pain (EXCELLENCE): a phase 3, randomized, placebo-controlled clinical trial","volume":"33","author":"Zhu","year":"2025","journal-title":"Osteoarthr. Cartil."},{"issue":"10","key":"10.1016\/j.ejpb.2026.114980_b0210","article-title":"Nanoengineered particles for enhanced intra-articular retention and delivery of proteins","volume":"3","author":"Singh","year":"2014","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.ejpb.2026.114980_b0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2125.1994.tb04365.x","article-title":"Disappearance kinetics of solutes from synovial fluid after intra-articular injection","volume":"38","author":"Owen","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.114980_b0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2015.12.015","article-title":"Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice","volume":"498","author":"Pradal","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40360-018-0230-5","article-title":"Cationic liposomes induce cytotoxicity in HepG2 via regulation of lipid metabolism based on whole-transcriptome sequencing analysis","volume":"19","author":"Li","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.ejpb.2026.114980_b0230","first-page":"59","article-title":"Signaling in Fibrosis: TGF-\u03b2, WNT, and YAP\/TAZ Converge","volume":"2","author":"Piersma","year":"2015","journal-title":"Front Med. (Lausanne)."},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12964-022-00881-9","article-title":"TGF-\u03b21 regulates chondrocyteproliferation and extracellular matrix synthesis via circPhf21a-Vegfa axis in osteoarthritis","volume":"20","author":"Lin","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ejpb.2026.114980_b0240","doi-asserted-by":"crossref","unstructured":"Y. Liao, Y. Ren, X. Luo, A.J. Mirando, J.T. Long, A. Leinroth et al., Interleukin-6 signaling mediates cartilage degradation and pain in posttraumatic osteoarthritis in a sex-specific manner. Sci. Signal. 15(744):eabn7082.","DOI":"10.1126\/scisignal.abn7082"},{"issue":"6","key":"10.1016\/j.ejpb.2026.114980_b0245","doi-asserted-by":"crossref","first-page":"R262","DOI":"10.1186\/ar4107","article-title":"Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration model","volume":"14","author":"Tsuchida","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.ejpb.2026.114980_b0250","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/nnm-2017-0335","article-title":"Chondrocyte affinity peptide modified PAMAM conjugate as a nanoplatform for targeting and retention in cartilage","volume":"13","author":"Hu","year":"2018","journal-title":"Nanomedicine (Lond.)"},{"issue":"2","key":"10.1016\/j.ejpb.2026.114980_b0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5603\/FHC.a2018.0009","article-title":"The concentration of ethanol affects its penetration rate in bovine cardiac and hepatic tissues","volume":"1","author":"Dunster-Jones","year":"2018","journal-title":"Folia Histochem. Cytobiol."},{"issue":"21","key":"10.1016\/j.ejpb.2026.114980_b0260","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1039\/D0RA01692F","article-title":"Molecular mechanism of the skin permeation enhancing effect of ethanol: a molecular dynamics study","volume":"10","author":"Gupta","year":"2020","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.ejpb.2026.114980_b0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.berh.2008.02.001","article-title":"Cartilage in normal and osteoarthritis conditions","volume":"22","author":"Martel-Pelletier","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0270","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biomaterials.2013.09.091","article-title":"Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis","volume":"35","author":"Bajpayee","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2026.114980_b0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.actbio.2022.10.007","article-title":"Nanodevices for deep cartilage penetration","volume":"154","author":"Xu","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2026.114980_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107627","article-title":"Promising LOX proteins for cartilage-targeting osteoarthritis therapy","volume":"212","author":"Morici","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.ejpb.2026.114980_b0285","first-page":"13","article-title":"Comparative digital cartilage histology for human and common osteoarthritis models","volume":"2013","author":"Pedersen","year":"2013","journal-title":"Orthop. Res. Rev."},{"issue":"2","key":"10.1016\/j.ejpb.2026.114980_b0290","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/ten.tec.2020.0309","article-title":"Current models for development of disease-modifying osteoarthritis drugs","volume":"27","author":"Makarczyk","year":"2021","journal-title":"Tissue Eng. Part C Methods"},{"issue":"37","key":"10.1016\/j.ejpb.2026.114980_b0295","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1016\/j.biomaterials.2014.08.042","article-title":"Intra-articular delivery of kartogenin-conjugated chitosan nano\/microparticles for cartilage regeneration","volume":"35","author":"Kang","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ejpb.2026.114980_b0300","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1302\/2046-3758.73.BJR-2017-0121.R2","article-title":"Comparison of pain behaviour and osteoarthritis progression between anterior cruciate ligament transection and osteochondral injury in rat models","volume":"7","author":"Tawonsawatruk","year":"2018","journal-title":"Bone Joint Res."},{"issue":"6","key":"10.1016\/j.ejpb.2026.114980_b0305","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.joca.2025.04.001","article-title":"Cartilage targeting cationic peptide carriers display deep cartilage penetration and retention in a rabbit model of post-traumatic osteoarthritis","volume":"33","author":"Boyer","year":"2025","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejpb.2026.114980_b0310","doi-asserted-by":"crossref","DOI":"10.1177\/20417314231172584","article-title":"Osteoarthritis models: from animals to tissue engineering","volume":"14","author":"Dou","year":"2023","journal-title":"J. Tissue Eng."},{"issue":"1","key":"10.1016\/j.ejpb.2026.114980_b0315","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jor.25969","article-title":"Osteoarthritis early-, mid- and late-stage progression in the rat medial meniscus transection model","volume":"43","author":"McKinney","year":"2025","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.ejpb.2026.114980_b0320","article-title":"Lipid nanoparticles in the development of mRNA vaccines for COVID-19","volume":"74","author":"Wilson","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"10.1016\/j.ejpb.2026.114980_b0325","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.joca.2025.04.006","article-title":"Intra-articular MM-II for the treatment of knee osteoarthritis pain: efficacy and safety results from a 26-week, phase 2b, placebo-controlled, double-blind, randomized dose-ranging trial","volume":"33","author":"Schnitzer","year":"2025","journal-title":"Osteoarthr. Cartil."},{"issue":"7","key":"10.1016\/j.ejpb.2026.114980_b0330","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.joca.2025.02.774","article-title":"Empty large liposomes reduce cartilage degeneration in osteoarthritic rats by forming a lubricative coating","volume":"33","author":"Wechsler","year":"2025","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejpb.2026.114980_b0335","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.580118","article-title":"Lipid nanoparticles as carriers for bioactive delivery","volume":"9","author":"Dhiman","year":"2021","journal-title":"Front. Chem."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T02:08:39Z","timestamp":1770084519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":67,"alternative-id":["S0939641126000019"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.114980","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cationic liposome-mediated intra-articular delivery of lorecivivint for osteoarthritis treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.114980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114980"}}